Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations ; volume:13 ; number:1 ; day:10 ; month:11 ; year:2022 ; pages:1-16 ; date:12.2022
Nature Communications ; 13, Heft 1 (10.11.2022), 1-16, 12.2022
- Creator
-
Alderwerelt van Rosenburgh, Iris K. van
Lu, David M.
Grant, Michael J.
Stayrook, Steven E.
Phadke, Manali
Walther, Zenta
Goldberg, Sarah B.
Politi, Katerina
Lemmon, Mark A.
Ashtekar, Kumar D.
Tsutsui, Yuko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-34398-z
- URN
-
urn:nbn:de:101:1-2023012421430435661195
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alderwerelt van Rosenburgh, Iris K. van
- Lu, David M.
- Grant, Michael J.
- Stayrook, Steven E.
- Phadke, Manali
- Walther, Zenta
- Goldberg, Sarah B.
- Politi, Katerina
- Lemmon, Mark A.
- Ashtekar, Kumar D.
- Tsutsui, Yuko
- SpringerLink (Online service)
Other Objects (12)
EGFR exon 20 insertion mutations in NSCLC
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options
Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations
Unexpected consequences: exon skipping caused by CRISPR-generated mutations
EGFR exon 20 insertion mutations in NSCLC
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options
Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations
Unexpected consequences: exon skipping caused by CRISPR-generated mutations
EGFR exon 20 insertion mutations in NSCLC
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options
Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability
eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations